APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Drug Safety Prediction Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Drug Safety Prediction Software Market Outlook and Growth Opportunities 2026

12 August 2026197 pages

Choose your research edition.

Industry ResearchAI Drug Safety Prediction Software Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Drug Safety Prediction Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal AI Drug Safety Prediction Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Drug Safety Prediction Software Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Drug Safety Prediction Software Market Analysis and Forecast 2026-2032171 pages · $4,950 USD

Market perspective

The global AI Drug Safety Prediction Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Drug Safety Prediction Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Drug Safety Prediction Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Drug Safety Prediction Software market include Certara, Lhasa Limited, Instem, ACD/Labs, Chemical Computing Group, Optibrium, MultiCASE, Insilico Medicine and MindRank, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Drug Safety Prediction Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Drug Safety Prediction Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Drug Safety Prediction Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Drug Safety Prediction Software market.

AI Drug Safety Prediction Software Segment by Company

Certara

Lhasa Limited

Instem

ACD/Labs

Chemical Computing Group

Optibrium

MultiCASE

Insilico Medicine

MindRank

Molecular Discovery

Molecular Networks

OASIS LMC

Simulations Plus

Dassault Systèmes

Schrödinger

AI Drug Safety Prediction Software Segment by Type

Integrated ADMET Prediction

Toxicity Endpoint Prediction

Drug-Drug Interaction and PK Safety Prediction

Metabolism and Metabolite Prediction

Off-Target and Safety Pharmacology Prediction

AI Drug Safety Prediction Software Segment by Application

Hit and Lead Screening

Lead Optimization

Candidate Selection

Preclinical Safety Assessment

Regulatory Safety Assessment

Other Drug Safety Research

AI Drug Safety Prediction Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Drug Safety Prediction Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Drug Safety Prediction Software key companies, revenue, market share, and recent developments.

3. To split the AI Drug Safety Prediction Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Drug Safety Prediction Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Drug Safety Prediction Software significant trends, drivers, influence factors in global and regions.

6. To analyze AI Drug Safety Prediction Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Drug Safety Prediction Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Drug Safety Prediction Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Drug Safety Prediction Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Drug Safety Prediction Software industry.

Chapter 3: Detailed analysis of AI Drug Safety Prediction Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Drug Safety Prediction Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Drug Safety Prediction Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Drug Safety Prediction Software Industry Trends Table 2. AI Drug Safety Prediction Software Industry Drivers Table 3. AI Drug Safety Prediction Software Industry Opportunities and Challenges Table 4. AI Drug Safety Prediction Software Industry Restraints Table 5. Global AI Drug Safety Prediction Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Drug Safety Prediction Software Revenue Share by Company (2021-2026) Table 7. Global AI Drug Safety Prediction Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Drug Safety Prediction Software Key Company Manufacturing Base & Headquarters Table 9. Global AI Drug Safety Prediction Software Company, Product Type & Application Table 10. Global AI Drug Safety Prediction Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Drug Safety Prediction Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Integrated ADMET Prediction Table 15. Significant Companies of Toxicity Endpoint Prediction Table 16. Significant Companies of Drug-Drug Interaction and PK Safety Prediction Table 17. Significant Companies of Metabolism and Metabolite Prediction Table 18. Significant Companies of Off-Target and Safety Pharmacology Prediction Table 19. Global AI Drug Safety Prediction Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global AI Drug Safety Prediction Software Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global AI Drug Safety Prediction Software Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global AI Drug Safety Prediction Software Sales Value Share by Type (2021-2026) Table 23. Global AI Drug Safety Prediction Software Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hit and Lead Screening Table 25. Significant Companies of Lead Optimization Table 26. Significant Companies of Candidate Selection Table 27. Significant Companies of Preclinical Safety Assessment Table 28. Significant Companies of Regulatory Safety Assessment Table 29. Significant Companies of Other Drug Safety Research Table 30. Global AI Drug Safety Prediction Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global AI Drug Safety Prediction Software Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global AI Drug Safety Prediction Software Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global AI Drug Safety Prediction Software Sales Value Share by Application (2021-2026) Table 34. Global AI Drug Safety Prediction Software Sales Value Share by Application (2027-2032) Table 35. Global AI Drug Safety Prediction Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global AI Drug Safety Prediction Software Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global AI Drug Safety Prediction Software Sales Value Share by Region (2021-2026) Table 38. Global AI Drug Safety Prediction Software Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global AI Drug Safety Prediction Software Sales Value Share by Region (2027-2032) Table 40. Global AI Drug Safety Prediction Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global AI Drug Safety Prediction Software Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global AI Drug Safety Prediction Software Sales Value Market Share by Country (2021-2026) Table 43. Global AI Drug Safety Prediction Software Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global AI Drug Safety Prediction Software Sales Value Market Share by Country (2027-2032) Table 45. Certara Company Information Table 46. Certara Business Overview Table 47. Certara AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Certara AI Drug Safety Prediction Software Product Portfolio Table 49. Certara Recent Development Table 50. Lhasa Limited Company Information Table 51. Lhasa Limited Business Overview Table 52. Lhasa Limited AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Lhasa Limited AI Drug Safety Prediction Software Product Portfolio Table 54. Lhasa Limited Recent Development Table 55. Instem Company Information Table 56. Instem Business Overview Table 57. Instem AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Instem AI Drug Safety Prediction Software Product Portfolio Table 59. Instem Recent Development Table 60. ACD/Labs Company Information Table 61. ACD/Labs Business Overview Table 62. ACD/Labs AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. ACD/Labs AI Drug Safety Prediction Software Product Portfolio Table 64. ACD/Labs Recent Development Table 65. Chemical Computing Group Company Information Table 66. Chemical Computing Group Business Overview Table 67. Chemical Computing Group AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio Table 69. Chemical Computing Group Recent Development Table 70. Optibrium Company Information Table 71. Optibrium Business Overview Table 72. Optibrium AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Optibrium AI Drug Safety Prediction Software Product Portfolio Table 74. Optibrium Recent Development Table 75. MultiCASE Company Information Table 76. MultiCASE Business Overview Table 77. MultiCASE AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. MultiCASE AI Drug Safety Prediction Software Product Portfolio Table 79. MultiCASE Recent Development Table 80. Insilico Medicine Company Information Table 81. Insilico Medicine Business Overview Table 82. Insilico Medicine AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Insilico Medicine AI Drug Safety Prediction Software Product Portfolio Table 84. Insilico Medicine Recent Development Table 85. MindRank Company Information Table 86. MindRank Business Overview Table 87. MindRank AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. MindRank AI Drug Safety Prediction Software Product Portfolio Table 89. MindRank Recent Development Table 90. Molecular Discovery Company Information Table 91. Molecular Discovery Business Overview Table 92. Molecular Discovery AI Drug Safety Prediction Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Molecular Discovery AI Drug Safety Prediction Software Product Portfolio Table 94. Molecular Discovery Recent Development Table 95. Molecular Networks Company Information Table 96. Molecular Networks Business Overview Table 97. Molecular Networks AI Drug Safety Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Molecular Networks AI Drug Safety Prediction Software Product Portfolio Table 99. Molecular Networks Recent Development Table 100. OASIS LMC Company Information Table 101. OASIS LMC Business Overview Table 102. OASIS LMC AI Drug Safety Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. OASIS LMC AI Drug Safety Prediction Software Product Portfolio Table 104. OASIS LMC Recent Development Table 105. Simulations Plus Company Information Table 106. Simulations Plus Business Overview Table 107. Simulations Plus AI Drug Safety Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Simulations Plus AI Drug Safety Prediction Software Product Portfolio Table 109. Simulations Plus Recent Development Table 110. Dassault Systèmes Company Information Table 111. Dassault Systèmes Business Overview Table 112. Dassault Systèmes AI Drug Safety Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio Table 114. Dassault Systèmes Recent Development Table 115. Schrödinger Company Information Table 116. Schrödinger Business Overview Table 117. Schrödinger AI Drug Safety Prediction Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Schrödinger AI Drug Safety Prediction Software Product Portfolio Table 119. Schrödinger Recent Development Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. AI Drug Safety Prediction Software Product Image Figure 2. Global AI Drug Safety Prediction Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Drug Safety Prediction Software Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Drug Safety Prediction Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Integrated ADMET Prediction Image Figure 8. Toxicity Endpoint Prediction Image Figure 9. Drug-Drug Interaction and PK Safety Prediction Image Figure 10. Metabolism and Metabolite Prediction Image Figure 11. Off-Target and Safety Pharmacology Prediction Image Figure 12. Global AI Drug Safety Prediction Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global AI Drug Safety Prediction Software Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global AI Drug Safety Prediction Software Sales Value Share by Type (2021-2032) Figure 15. Hit and Lead Screening Image Figure 16. Lead Optimization Image Figure 17. Candidate Selection Image Figure 18. Preclinical Safety Assessment Image Figure 19. Regulatory Safety Assessment Image Figure 20. Other Drug Safety Research Image Figure 21. Global AI Drug Safety Prediction Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global AI Drug Safety Prediction Software Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global AI Drug Safety Prediction Software Sales Value Share by Application (2021-2032) Figure 24. Global AI Drug Safety Prediction Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global AI Drug Safety Prediction Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America AI Drug Safety Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 27. North America AI Drug Safety Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe AI Drug Safety Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 29. Europe AI Drug Safety Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific AI Drug Safety Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific AI Drug Safety Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America AI Drug Safety Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 33. South America AI Drug Safety Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa AI Drug Safety Prediction Software Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa AI Drug Safety Prediction Software Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Integrated ADMET Prediction
  • Toxicity Endpoint Prediction
  • Drug-Drug Interaction and PK Safety Prediction
  • Metabolism and Metabolite Prediction
  • Off-Target and Safety Pharmacology Prediction
Applications
  • Hit and Lead Screening
  • Lead Optimization
  • Candidate Selection
  • Preclinical Safety Assessment
  • Regulatory Safety Assessment
  • Other Drug Safety Research
Companies covered
  • Certara
  • Lhasa Limited
  • Instem
  • ACD/Labs
  • Chemical Computing Group
  • Optibrium
  • MultiCASE
  • Insilico Medicine
  • MindRank
  • Molecular Discovery
  • Molecular Networks
  • OASIS LMC
  • Simulations Plus
  • Dassault Systèmes
  • Schrödinger

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Drug Safety Prediction Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Drug Safety Prediction Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Drug Safety Prediction Software Market Dynamics
  1. 2.1 AI Drug Safety Prediction Software Industry Trends
  2. 2.2 AI Drug Safety Prediction Software Industry Drivers
  3. 2.3 AI Drug Safety Prediction Software Industry Opportunities and Challenges
  4. 2.4 AI Drug Safety Prediction Software Industry Restraints
3 AI Drug Safety Prediction Software Market by Company
  1. 3.1 Global AI Drug Safety Prediction Software Company Revenue Ranking in 2025
  2. 3.2 Global AI Drug Safety Prediction Software Revenue by Company (2021-2026)
  3. 3.3 Global AI Drug Safety Prediction Software Company Ranking (2024-2026)
  4. 3.4 Global AI Drug Safety Prediction Software Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Drug Safety Prediction Software Company Product Type and Application
  6. 3.6 Global AI Drug Safety Prediction Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Drug Safety Prediction Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Drug Safety Prediction Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Drug Safety Prediction Software Market by Type
  1. 4.1 AI Drug Safety Prediction Software Type Introduction
  2. 4.1.1 Integrated ADMET Prediction
  3. 4.1.2 Toxicity Endpoint Prediction
  4. 4.1.3 Drug-Drug Interaction and PK Safety Prediction
  5. 4.1.4 Metabolism and Metabolite Prediction
  6. 4.1.5 Off-Target and Safety Pharmacology Prediction
  7. 4.2 Global AI Drug Safety Prediction Software Sales Value by Type
  8. 4.2.1 Global AI Drug Safety Prediction Software Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global AI Drug Safety Prediction Software Sales Value by Type (2021-2032)
  10. 4.2.3 Global AI Drug Safety Prediction Software Sales Value Share by Type (2021-2032)
5 AI Drug Safety Prediction Software Market by Application
  1. 5.1 AI Drug Safety Prediction Software Application Introduction
  2. 5.1.1 Hit and Lead Screening
  3. 5.1.2 Lead Optimization
  4. 5.1.3 Candidate Selection
  5. 5.1.4 Preclinical Safety Assessment
  6. 5.1.5 Regulatory Safety Assessment
  7. 5.1.6 Other Drug Safety Research
  8. 5.2 Global AI Drug Safety Prediction Software Sales Value by Application
  9. 5.2.1 Global AI Drug Safety Prediction Software Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global AI Drug Safety Prediction Software Sales Value by Application (2021-2032)
  11. 5.2.3 Global AI Drug Safety Prediction Software Sales Value Share by Application (2021-2032)
6 AI Drug Safety Prediction Software Regional Value Analysis
  1. 6.1 Global AI Drug Safety Prediction Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Drug Safety Prediction Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Drug Safety Prediction Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Drug Safety Prediction Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Drug Safety Prediction Software Sales Value (2021-2032)
  7. 6.3.2 North America AI Drug Safety Prediction Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Drug Safety Prediction Software Sales Value (2021-2032)
  10. 6.4.2 Europe AI Drug Safety Prediction Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Drug Safety Prediction Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Drug Safety Prediction Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Drug Safety Prediction Software Sales Value (2021-2032)
  16. 6.6.2 South America AI Drug Safety Prediction Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Drug Safety Prediction Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Drug Safety Prediction Software Sales Value Share by Country, 2025 VS 2032
7 AI Drug Safety Prediction Software Country-level Value Analysis
  1. 7.1 Global AI Drug Safety Prediction Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Drug Safety Prediction Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Drug Safety Prediction Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Drug Safety Prediction Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Drug Safety Prediction Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Drug Safety Prediction Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Drug Safety Prediction Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Certara
  2. 8.1.1 Certara Company Information
  3. 8.1.2 Certara Business Overview
  4. 8.1.3 Certara AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Certara AI Drug Safety Prediction Software Product Portfolio
  6. 8.1.5 Certara Recent Developments
  7. 8.2 Lhasa Limited
  8. 8.2.1 Lhasa Limited Company Information
  9. 8.2.2 Lhasa Limited Business Overview
  10. 8.2.3 Lhasa Limited AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Lhasa Limited AI Drug Safety Prediction Software Product Portfolio
  12. 8.2.5 Lhasa Limited Recent Developments
  13. 8.3 Instem
  14. 8.3.1 Instem Company Information
  15. 8.3.2 Instem Business Overview
  16. 8.3.3 Instem AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Instem AI Drug Safety Prediction Software Product Portfolio
  18. 8.3.5 Instem Recent Developments
  19. 8.4 ACD/Labs
  20. 8.4.1 ACD/Labs Company Information
  21. 8.4.2 ACD/Labs Business Overview
  22. 8.4.3 ACD/Labs AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ACD/Labs AI Drug Safety Prediction Software Product Portfolio
  24. 8.4.5 ACD/Labs Recent Developments
  25. 8.5 Chemical Computing Group
  26. 8.5.1 Chemical Computing Group Company Information
  27. 8.5.2 Chemical Computing Group Business Overview
  28. 8.5.3 Chemical Computing Group AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Chemical Computing Group AI Drug Safety Prediction Software Product Portfolio
  30. 8.5.5 Chemical Computing Group Recent Developments
  31. 8.6 Optibrium
  32. 8.6.1 Optibrium Company Information
  33. 8.6.2 Optibrium Business Overview
  34. 8.6.3 Optibrium AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Optibrium AI Drug Safety Prediction Software Product Portfolio
  36. 8.6.5 Optibrium Recent Developments
  37. 8.7 MultiCASE
  38. 8.7.1 MultiCASE Company Information
  39. 8.7.2 MultiCASE Business Overview
  40. 8.7.3 MultiCASE AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 MultiCASE AI Drug Safety Prediction Software Product Portfolio
  42. 8.7.5 MultiCASE Recent Developments
  43. 8.8 Insilico Medicine
  44. 8.8.1 Insilico Medicine Company Information
  45. 8.8.2 Insilico Medicine Business Overview
  46. 8.8.3 Insilico Medicine AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Insilico Medicine AI Drug Safety Prediction Software Product Portfolio
  48. 8.8.5 Insilico Medicine Recent Developments
  49. 8.9 MindRank
  50. 8.9.1 MindRank Company Information
  51. 8.9.2 MindRank Business Overview
  52. 8.9.3 MindRank AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 MindRank AI Drug Safety Prediction Software Product Portfolio
  54. 8.9.5 MindRank Recent Developments
  55. 8.10 Molecular Discovery
  56. 8.10.1 Molecular Discovery Company Information
  57. 8.10.2 Molecular Discovery Business Overview
  58. 8.10.3 Molecular Discovery AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Molecular Discovery AI Drug Safety Prediction Software Product Portfolio
  60. 8.10.5 Molecular Discovery Recent Developments
  61. 8.11 Molecular Networks
  62. 8.11.1 Molecular Networks Company Information
  63. 8.11.2 Molecular Networks Business Overview
  64. 8.11.3 Molecular Networks AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Molecular Networks AI Drug Safety Prediction Software Product Portfolio
  66. 8.11.5 Molecular Networks Recent Developments
  67. 8.12 OASIS LMC
  68. 8.12.1 OASIS LMC Company Information
  69. 8.12.2 OASIS LMC Business Overview
  70. 8.12.3 OASIS LMC AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 OASIS LMC AI Drug Safety Prediction Software Product Portfolio
  72. 8.12.5 OASIS LMC Recent Developments
  73. 8.13 Simulations Plus
  74. 8.13.1 Simulations Plus Company Information
  75. 8.13.2 Simulations Plus Business Overview
  76. 8.13.3 Simulations Plus AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Simulations Plus AI Drug Safety Prediction Software Product Portfolio
  78. 8.13.5 Simulations Plus Recent Developments
  79. 8.14 Dassault Systèmes
  80. 8.14.1 Dassault Systèmes Company Information
  81. 8.14.2 Dassault Systèmes Business Overview
  82. 8.14.3 Dassault Systèmes AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Dassault Systèmes AI Drug Safety Prediction Software Product Portfolio
  84. 8.14.5 Dassault Systèmes Recent Developments
  85. 8.15 Schrödinger
  86. 8.15.1 Schrödinger Company Information
  87. 8.15.2 Schrödinger Business Overview
  88. 8.15.3 Schrödinger AI Drug Safety Prediction Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Schrödinger AI Drug Safety Prediction Software Product Portfolio
  90. 8.15.5 Schrödinger Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst